Immunocore Holdings plc
IMCR
$31.16
-$0.05-0.16%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 11.69% | 4.74% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 11.69% | 4.74% | |||
| Cost of Revenue | 100.56% | -386.44% | |||
| Gross Profit | -59.77% | 701.70% | |||
| SG&A Expenses | -5.02% | 19.12% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 14.09% | -3.71% | |||
| Operating Income | -158.10% | 83.52% | |||
| Income Before Tax | 124.51% | -507.37% | |||
| Income Tax Expenses | 201.05% | 60.27% | |||
| Earnings from Continuing Operations | 121.13% | -372.10% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 121.13% | -372.10% | |||
| EBIT | -158.10% | 83.52% | |||
| EBITDA | -1,075.32% | 96.85% | |||
| EPS Basic | 121.12% | -372.05% | |||
| Normalized Basic EPS | 102.94% | -444.15% | |||
| EPS Diluted | 121.05% | -379.41% | |||
| Normalized Diluted EPS | 102.83% | -463.25% | |||
| Average Basic Shares Outstanding | 0.08% | 0.05% | |||
| Average Diluted Shares Outstanding | 3.80% | -5.23% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||